Business Description
Shoulder Innovations Inc
NAICS : 339112
SIC : 3841
ISIN : US82537J1088
Total Employee Number:
75Description
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 7.23 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | -0.36 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 9.87 | |||||
Beneish M-Score | -2.04 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 26.79 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 30.63 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 85.39 | |||||
9-Day RSI | 80.14 | |||||
14-Day RSI | 76.45 | |||||
3-1 Month Momentum % | 1.63 | |||||
6-1 Month Momentum % | -3.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.81 | |||||
Quick Ratio | 10.04 | |||||
Cash Ratio | 8.8 | |||||
Days Inventory | 543.07 | |||||
Days Sales Outstanding | 53.31 | |||||
Days Payable | 188.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.04 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 76.81 | |||||
Operating Margin % | -57.48 | |||||
Net Margin % | -81.78 | |||||
EBITDA Margin % | -76.63 | |||||
FCF Margin % | -81.22 | |||||
OCF Margin % | -63.98 | |||||
ROE % | -77.58 | |||||
ROA % | -34.25 | |||||
ROIC % | -102.8 | |||||
ROC (Joel Greenblatt) % | -155.66 | |||||
ROCE % | -38.61 | |||||
Moat Score | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 7.82 | |||||
PB Ratio | 3.55 | |||||
Price-to-Tangible-Book | 3.55 | |||||
EV-to-EBIT | -8.43 | |||||
EV-to-EBITDA | -9.18 | |||||
EV-to-Revenue | 7.03 | |||||
EV-to-FCF | -8.66 | |||||
| Price-to-Net-Current-Asset-Value | 3.99 | |||||
| Price-to-Net-Cash | 5.81 | |||||
Earnings Yield (Greenblatt) % | -11.86 | |||||
FCF Yield % | -9.27 |
GF Valueâ„¢
Shoulder Innovations Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shoulder Innovations Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-11 16:30 | In 137 days | ||
| Third quarter earnings results for 2026 | 2026-11-11 | In 136 days | ||
| Second quarter earnings results for 2026 | 2026-09-09 | In 73 days | ||
| General meeting for 2026 | 2026-06-26 15:00 | 17.20 (+0.00%) | ||
| Goldman Sachs 47th Annual Global Healthcare Conference | 2026-06-09 | 12.20 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 16:30 | 11.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 11.00 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-10 16:30 | 11.10 (+0.00%) | ||
| Annual report for 2025 | 2026-03-10 | 11.10 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-10 | 11.10 (+0.00%) |
Show
Entries
Press Release
Articles on Shoulder Innovations Inc
No articles.